HomeATAI • NASDAQ
add
ATAI Life Sciences NV
Previous close
$1.32
Day range
$1.30 - $1.40
Year range
$1.02 - $2.85
Market cap
219.28M USD
Avg Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 22.18M | -26.18% |
Net income | -26.71M | 19.38% |
Net profit margin | — | — |
Earnings per share | -0.17 | 19.05% |
EBITDA | -22.10M | 26.20% |
Effective tax rate | 0.76% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 106.25M | -57.48% |
Total assets | 269.12M | -4.13% |
Total liabilities | 45.86M | 14.44% |
Total equity | 223.26M | — |
Shares outstanding | 167.41M | — |
Price to book | 0.99 | — |
Return on assets | -19.72% | — |
Return on capital | -21.66% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -26.71M | 19.38% |
Cash from operations | -22.57M | -6.93% |
Cash from investing | 11.47M | -28.39% |
Cash from financing | — | — |
Net change in cash | -11.17M | -136.17% |
Free cash flow | -18.35M | -23.38% |
About
Founded
2018
Website
Employees
83